Diabetic Neurological Disorder Therapeutic Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: D65277BBAEE8EN
Market Monitor Global

Abstracts

A drug used to treat mental illness caused by diabetes

This report contains market size and forecasts of Diabetic Neurological Disorder Therapeutic Drug in Global, including the following market information:

Global Diabetic Neurological Disorder Therapeutic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Diabetic Neurological Disorder Therapeutic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetic Neurological Disorder Therapeutic Drug include AstraZeneca, Johnson & Johnson, Takeda, Mitsubishi Chemical, Avanir Pharmaceuticals, Dong-A Pharmaceutical Co., Ltd., Immune Pharmaceuticals, MediciNova and Sangamo BioSciences. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Neurological Disorder Therapeutic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetic Neurological Disorder Therapeutic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Neurological Disorder Therapeutic Drug Market Segment Percentages, by Type, 2021 (%)

• Capsule
• Pills
• Other

Global Diabetic Neurological Disorder Therapeutic Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Diabetic Neurological Disorder Therapeutic Drug Market Segment Percentages, by Application, 2021 (%)

• Symmetrical Neuropathy
• Focal and Multifocal Neuropathy

Global Diabetic Neurological Disorder Therapeutic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Diabetic Neurological Disorder Therapeutic Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Diabetic Neurological Disorder Therapeutic Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Diabetic Neurological Disorder Therapeutic Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Johnson & Johnson
• Takeda
• Mitsubishi Chemical
• Avanir Pharmaceuticals
• Dong-A Pharmaceutical Co., Ltd.
• Immune Pharmaceuticals
• MediciNova
• Sangamo BioSciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Diabetic Neurological Disorder Therapeutic Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Diabetic Neurological Disorder Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL DIABETIC NEUROLOGICAL DISORDER THERAPEUTIC DRUG OVERALL MARKET SIZE

2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size: 2021 VS 2028
2.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Diabetic Neurological Disorder Therapeutic Drug Players in Global Market
3.2 Top Global Diabetic Neurological Disorder Therapeutic Drug Companies Ranked by Revenue
3.3 Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Neurological Disorder Therapeutic Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetic Neurological Disorder Therapeutic Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Neurological Disorder Therapeutic Drug Players in Global Market
  3.6.1 List of Global Tier 1 Diabetic Neurological Disorder Therapeutic Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Diabetic Neurological Disorder Therapeutic Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Diabetic Neurological Disorder Therapeutic Drug Market Size Markets, 2021 & 2028
  4.1.2 Capsule
  4.1.3 Pills
  4.1.4 Other
4.2 By Type - Global Diabetic Neurological Disorder Therapeutic Drug Revenue & Forecasts
  4.2.1 By Type - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2022
  4.2.2 By Type - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2023-2028
  4.2.3 By Type - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Diabetic Neurological Disorder Therapeutic Drug Market Size, 2021 & 2028
  5.1.2 Symmetrical Neuropathy
  5.1.3 Focal and Multifocal Neuropathy
5.2 By Application - Global Diabetic Neurological Disorder Therapeutic Drug Revenue & Forecasts
  5.2.1 By Application - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2022
  5.2.2 By Application - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2023-2028
  5.2.3 By Application - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Diabetic Neurological Disorder Therapeutic Drug Market Size, 2021 & 2028
6.2 By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue & Forecasts
  6.2.1 By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2022
  6.2.2 By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2023-2028
  6.2.3 By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028
  6.3.2 US Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.3.3 Canada Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.3.4 Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028
  6.4.2 Germany Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.3 France Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.4 U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.5 Italy Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.6 Russia Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.4.8 Benelux Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028
  6.5.2 China Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.5.3 Japan Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.5.4 South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.5.6 India Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028
  6.6.2 Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.6.3 Argentina Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028
  6.7.2 Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.7.3 Israel Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028
  6.7.5 UAE Diabetic Neurological Disorder Therapeutic Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.1.4 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.2.4 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.3.4 Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.3.5 Takeda Key News
7.4 Mitsubishi Chemical
  7.4.1 Mitsubishi Chemical Corporate Summary
  7.4.2 Mitsubishi Chemical Business Overview
  7.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.4.4 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.4.5 Mitsubishi Chemical Key News
7.5 Avanir Pharmaceuticals
  7.5.1 Avanir Pharmaceuticals Corporate Summary
  7.5.2 Avanir Pharmaceuticals Business Overview
  7.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.5.4 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.5.5 Avanir Pharmaceuticals Key News
7.6 Dong-A Pharmaceutical Co., Ltd.
  7.6.1 Dong-A Pharmaceutical Co., Ltd. Corporate Summary
  7.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview
  7.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.6.4 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.6.5 Dong-A Pharmaceutical Co., Ltd. Key News
7.7 Immune Pharmaceuticals
  7.7.1 Immune Pharmaceuticals Corporate Summary
  7.7.2 Immune Pharmaceuticals Business Overview
  7.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.7.4 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.7.5 Immune Pharmaceuticals Key News
7.8 MediciNova
  7.8.1 MediciNova Corporate Summary
  7.8.2 MediciNova Business Overview
  7.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.8.4 MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.8.5 MediciNova Key News
7.9 Sangamo BioSciences
  7.9.1 Sangamo BioSciences Corporate Summary
  7.9.2 Sangamo BioSciences Business Overview
  7.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Major Product Offerings
  7.9.4 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue in Global Market (2017-2022)
  7.9.5 Sangamo BioSciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Diabetic Neurological Disorder Therapeutic Drug Market Opportunities & Trends in Global Market
Table 2. Diabetic Neurological Disorder Therapeutic Drug Market Drivers in Global Market
Table 3. Diabetic Neurological Disorder Therapeutic Drug Market Restraints in Global Market
Table 4. Key Players of Diabetic Neurological Disorder Therapeutic Drug in Global Market
Table 5. Top Diabetic Neurological Disorder Therapeutic Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetic Neurological Disorder Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Diabetic Neurological Disorder Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Neurological Disorder Therapeutic Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetic Neurological Disorder Therapeutic Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetic Neurological Disorder Therapeutic Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Diabetic Neurological Disorder Therapeutic Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Diabetic Neurological Disorder Therapeutic Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 32. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 35. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 38. Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 39. Mitsubishi Chemical Corporate Summary
Table 40. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 41. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 42. Avanir Pharmaceuticals Corporate Summary
Table 43. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 44. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 45. Dong-A Pharmaceutical Co., Ltd. Corporate Summary
Table 46. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 47. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 48. Immune Pharmaceuticals Corporate Summary
Table 49. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 50. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 51. MediciNova Corporate Summary
Table 52. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 53. MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)
Table 54. Sangamo BioSciences Corporate Summary
Table 55. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product Offerings
Table 56. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Diabetic Neurological Disorder Therapeutic Drug Segment by Type in 2021
Figure 2. Diabetic Neurological Disorder Therapeutic Drug Segment by Application in 2021
Figure 3. Global Diabetic Neurological Disorder Therapeutic Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetic Neurological Disorder Therapeutic Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2021
Figure 8. By Type - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 12. US Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 16. Germany Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 24. China Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetic Neurological Disorder Therapeutic Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MediciNova Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)